🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
02/03/1989 0,0652 USD
29/11/1988 0,0588 USD
29/08/1988 0,0469 USD
03/06/1988 0,0509 USD
29/02/1988 0,0509 USD
01/12/1987 0,0424 USD
28/08/1987 0,0424 USD
02/06/1987 0,0292 USD
02/03/1987 0,0292 USD
02/12/1986 0,0292 USD
02/09/1986 0,0292 USD
03/06/1986 0,0239 USD
27/02/1986 0,0239 USD
03/12/1985 0,0239 USD
30/08/1985 0,0212 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/03/1970 1,44 1,45 1,41 1,42 -1,38% 2,76% 611.194
27/02/1970 1,45 1,45 1,41 1,44 -0,45% 2,52% 1.516.666
26/02/1970 1,49 1,49 1,45 1,45 -2,45% 2,56% 2.127.859
25/02/1970 1,48 1,49 1,46 1,49 +0,56% 1,57% 1.411.027
24/02/1970 1,46 1,48 1,46 1,48 +1,71% 1,59% 807.379
20/02/1970 1,44 1,46 1,43 1,45 +1,15% 1,84% 1.335.571
19/02/1970 1,44 1,44 1,43 1,44 +0,11% 1,04% 965.837
18/02/1970 1,45 1,45 1,43 1,44 -1,59% 1,60% 1.795.853
17/02/1970 1,46 1,47 1,45 1,46 -0,23% 1,13% 1.720.397
16/02/1970 1,45 1,47 1,45 1,46 +0,57% 1,37% 731.923
13/02/1970 1,45 1,46 1,45 1,45 +0,92% 0,68% 626.285
12/02/1970 1,44 1,45 1,44 1,44 +0,69% 1,15% 618.739
11/02/1970 1,42 1,43 1,42 1,43 +0,46% 0,93% 384.826
10/02/1970 1,43 1,44 1,42 1,42 -0,46% 1,62% 460.282
09/02/1970 1,42 1,44 1,42 1,43 +1,41% 1,16% 822.470
06/02/1970 1,43 1,43 1,40 1,41 -1,16% 1,97% 316.915
05/02/1970 1,42 1,43 1,42 1,43 +1,18% 0,82% 513.101
04/02/1970 1,44 1,44 1,39 1,41 -2,74% 3,68% 1.546.848
03/02/1970 1,38 1,45 1,38 1,45 +6,83% 5,54% 2.286.317
02/02/1970 1,35 1,36 1,35 1,36 +1,49% 0,86% 852.653
30/01/1970 1,35 1,39 1,34 1,34 -0,98% 3,68% 1.524.211
29/01/1970 1,37 1,38 1,31 1,35 -1,21% 4,60% 1.275.206
28/01/1970 1,38 1,38 1,37 1,37 -1,67% 1,44% 958.291
27/01/1970 1,38 1,40 1,37 1,39 +0,48% 2,16% 1.682.669
26/01/1970 1,43 1,43 1,38 1,38 -4,13% 3,24% 1.312.934
23/01/1970 1,45 1,46 1,44 1,44 -0,45% 1,72% 1.018.656
22/01/1970 1,45 1,45 1,44 1,45 -0,45% 0,92% 830.016
21/01/1970 1,45 1,46 1,44 1,46 +0,68% 1,26% 1.094.112
20/01/1970 1,44 1,45 1,43 1,45 +0,70% 0,92% 913.018
19/01/1970 1,45 1,45 1,43 1,44 -1,37% 1,37% 3.259.699